The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1238-1247

  Chadet, Stéphanie ^a,b   Jelassi, Bilel ^a   Wannous, Ramez ^a   Angoulvant, Denis ^b   Chevalier, Stéphan ^a   Besson, Pierre ^a   Roger, Sébastien ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b FHU SUPORT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y5 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC P2Y7 RECEPTOR; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MCF 7 CELL LINE; METASTASIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR INVASION; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; RNA INTERFERENCE;

ADENOSINE TRIPHOSPHATE; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; RECEPTORS, PURINERGIC P2Y2; RNA INTERFERENCE;

EID: 84896699500     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt493     Document Type: Article

References (55)

1. Burnstock, G. et al. (2010) The birth and postnatal development of purinergic signalling. Acta Physiol. (Oxf.), 199, 93-147.
2. Burnstock, G. (2006) Purinergic signalling. Br. J. Pharmacol., 147 (suppl. 1), S172-S181.
3. Burnstock, G. (2007) Purine and pyrimidine receptors. Cell. Mol. Life Sci., 64, 1471-1483.
4. North, R.A. (2002) Molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
5. Surprenant, A. et al. (2009) Signaling at purinergic P2X receptors. Annu. Rev. Physiol., 71, 333-359.
6. Burnstock, G. et al. (2013) Purinergic signalling and cancer. Purinergic Signal.
7. Pellegatti, P. et al. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One, 3, e2599.
8. Raffaghello, L. et al. (2006) The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res., 66, 907-914.
9. Wang, X. et al. (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med., 10, 821-827.
10. White, N. et al. (2006) P2 receptors and cancer. Trends Pharmacol. Sci., 27, 211-217.
11. Roger, S. et al. (2011) P2X7 receptor antagonism in the treatment of cancers. Expert Opin. Investig. Drugs, 20, 875-880.
12. Stagg, J. et al. (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene, 29, 5346-5358.
13. Parkin, D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
14. Jelassi, B. et al. (2011) P2X(7) receptor activation enhances SK3 channelsand cystein cathepsin-dependent cancer cells invasiveness. Oncogene, 30, 2108-2122.
15. Jelassi, B. et al. (2013) Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. Carcinogenesis, 34, 1487-1496.
16. Gillet, L. et al. (2009) Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J. Biol. Chem., 284, 8680-8691.
17. Roger, S. et al. (2008) Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J. Neurosci., 28, 6393-6401.
18. Brisson, L. et al. (2013) NaV1.5 sodium channels allosterically regulate the NHE-1 exchanger and promote breast cancer cell invadopodial activity. J. Cell Sci., 126(Pt 21):4835-4842. doi: 10.1242/jcs.123901. [Epub 31 July 2013].
19. Friedl, P. et al. (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell, 147, 992-1009.
20. Bours, M.J. et al. (2006) Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther., 112, 358-404.
21. Abbracchio, M.P. et al. (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev., 58, 281-341.
22. Maruoka, H. et al. (2011) Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate d-ester modifications as selective agonists of the P2Y(4) receptor. J. Med. Chem., 54, 4018-4033.
23. Rapaport, E. (1988) Experimental cancer therapy in mice by adenine nucleotides. Eur. J. Cancer Clin. Oncol., 24, 1491-1497.
24. Rapaport, E. (1983) Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J. Cell. Physiol., 114, 279-283.
25. Rapaport, E. et al. (1989) Generation of extracellular ATP in blood and its mediated inhibition of host weight loss in tumor-bearing mice. Biochem. Pharmacol., 38, 4261-4266.
26. Rapaport, E. (1990) Mechanisms of anticancer activities of adenine nucleotides in tumor-bearing hosts. Ann. N. Y. Acad. Sci., 603, 142-149; discussion 149-150.
27. Buzzi, N. et al. (2010) Signal transduction pathways associated with ATPinduced proliferation of colon adenocarcinoma cells. Biochim. Biophys. Acta, 1800, 946-955.
28. Popper, L.D. et al. (1993) Calcium mobilization and cell proliferation activated by extracellular ATP in human ovarian tumour cells. Cell Calcium, 14, 209-218.
29. Schafer, R. et al. (2003) ATP-and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 285, L376-L385.
30. Yaguchi, T. et al. (2010) Higher concentrations of extracellular ATP suppress proliferation of Caco-2 human colonic cancer cells via an unknown receptor involving PKC inhibition. Cell. Physiol. Biochem., 26, 125-134.
31. Ledur, P.F. et al. (2012) Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells. Purinergic Signal., 8, 39-48.
32. Shabbir, M. et al. (2008) Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int., 101, 352-359.
33. Wei, Q. et al. (2012) Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells. Biochem. Pharmacol., 82, 418-425.
34. Adinolfi, E. et al. (2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood, 99, 706-708.
35. Wang, Q. et al. (2004) P2X7 receptor-mediated apoptosis of human cervical epithelial cells. Am. J. Physiol. Cell Physiol., 287, C1349-C1358.
36. Zhang, X.J. et al. (2004) Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk. Res., 28, 1313-1322.
37. Slater, M. et al. (2004) Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res. Treat., 83, 1-10.
38. Slater, M. et al. (2004) Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology, 44, 206-215.
39. Deli, T. et al. (2007) Functional genomics of calcium channels in human melanoma cells. Int. J. Cancer, 121, 55-65.
40. Solini, A. et al. (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology, 149, 389-396.
41. Slater, M. et al. (2005) Expression of the apoptotic calcium channel P2X7 in the glandular epithelium. J. Mol. Histol., 36, 159-165.
42. Di Virgilio, F. et al. (2009) P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signal., 5, 251-256.
43. Adinolfi, E. et al. (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res., 72, 2957-2969.
44. Bilbao, P.S. et al. (2010) ATP stimulates the proliferation of MCF-7 cells through the PI3K/Akt signaling pathway. Arch. Biochem. Biophys., 499, 40-48.
45. Scodelaro Bilbao, P. et al. (2010) ATP modulates transcription factors through P2Y2 and P2Y4 receptors via PKC/MAPKs and PKC/Src pathways in MCF-7 cells. Arch. Biochem. Biophys., 494, 7-14.
46. Li, H.J. et al. (2011) P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol. Cell. Endocrinol., 338, 28-37.
47. Roger, S. et al. (2010) C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J. Biol. Chem., 285, 17514-17524.
48. Vandewalle, B. et al. (1994) Effect of extracellular ATP on breast tumor cell growth, implication of intracellular calcium. Cancer Lett., 85, 47-54.
49. Dixon, C.J. et al. (1997) Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br. J. Cancer, 75, 34-39.
50. Wagstaff, S.C. et al. (2000) Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells. Carcinogenesis, 21, 2175-2181.
51. Chen, L. et al. (2004) ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett., 215, 239-247.
52. Ando, K. et al. (2010) P2Y2 receptor-Gq/11 signaling at lipid rafts is required for UTP-induced cell migration in NG 108-15 cells. J. Pharmacol. Exp. Ther., 334, 809-819.
53. Chen, Y. et al. (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science, 314, 1792-1795.
54. Boucher, I. et al. (2010) The P2Y2 receptor mediates the epithelial injury response and cell migration. Am. J. Physiol. Cell Physiol., 299, C411-C421.
55. Schumacher, D. et al. (2013) Platelet-derived nucleotides promote tumorcell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell, 24, 130-137.